New app aims to empower hepatitis delta patients in their own care
NCT ID NCT07442760
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a mobile app called ePro-Diary HDV for people with hepatitis Delta, a rare but serious liver disease. The app helps patients track their health, communicate with doctors, and remember appointments. Researchers want to see if using the app helps patients attend more follow-up visits and improves their quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mobile application (ePro-Diary HDV)
What this could lead to
If successful, this app could help patients with hepatitis Delta stay on track with their care and improve communication with their doctors.
What could go wrong
This is a small, early study testing a digital tool, not a new drug. The app may not work for everyone or may not improve health outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ASST-Papa Giovanni XXIII
RECRUITINGBergamo, Italy, 24127, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••